AzTrials
AzTrials

Postoperative PainPhase 2NCT02401529

Effect of Steroids on Post-tonsillectomy Morbidities

A Phase 2 study testing IV dexamethasone, Oral prednisolone and Paracetamol in people with Postoperative Pain and Postoperative Nausea and Vomiting, run by King Fahd General Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy morbidities. Read more about this study

Who is it for?
Ages 5 to 20 yearsHealthy volunteers can take part
What is being tested?
IV dexamethasone, Oral prednisolone and Paracetamol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
Jan 2013to Mar 2014
Phase
Phase 2
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 20 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patients in the waiting list for tonsillectomy under general anesthesia who accepted to participate in the study.

Who cannot join

  • Patients who are allergic to steroids or those who have medical conditions which contraindicate the use of steroid i.e diabetes mellitus, gastritis, or hypertension and those who were on exogenous steroid supplements.

About this study

This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy morbidities. Half of the patients who comply with the inclusion criteria were selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo.

Read the detailed description

The effect of preoperative systemic steroids on post-tonsillectomy morbidities such as pain, nausea, vomiting and delayed feeding was proven. However, this study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on the aforementioned morbidities and on decreasing the duration and costs of hospital stays. patients who were in the waiting list for tonsillectomy procedure were screened for medical history and those who comply with the inclusion criteria were randomly assigned into two equal groups of 50 patients each. One group was selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo. Questionnaires investigating postoperative pain, nausea, vomiting, and oral intake were answered by patients, parents or guardians where applicable.

Being tested
IV dexamethasone, Oral prednisolone, Paracetamol, IV saline
Keywords
Dexamethasone, Prednisolone, Tonsillectomy Nausea, Pain, Postoperative, Postoperative Nausea and Vomiting, Randomized controlled trial, Post-tonsillectomy pain, delayed feeding
Medical subject headings
Pain, Postoperative, Postoperative Nausea and Vomiting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IV dexamethasoneDrug

    Also called Decadron

    0.15 mg/kg

  • Oral prednisoloneDrug

    Also called Predosone

    0.25mg/kg/day for 7 days then tapering for next 7 days

  • ParacetamolDrug

    Also called Adol

    acetaminophen 15 mg/kg/dose every 6 hours

  • IV salineDrug

    Also called Saline

    IV saline

Study groups in NCT02401529
Study groupRoleWhat they receive
IV dexamethasone and oral PrednisoloneExperimentalSingle dose of intravenous dexamethasone given immediately following surgery (0.15 mg/kg), followed by oral Prednisolone (0.25mg/kg/day for 7 days then tapering for next 7 days) and paracetamol (acetaminophen 15 mg/kg/dose every 6 hours).
Receives: Drug: IV dexamethasone; Drug: Oral prednisolone; Drug: Paracetamol
PlaceboActive comparatorPlacebo (IV saline) and paracetamol (acetaminophen 15 mg/kg/dose every 6 hours).
Receives: Drug: Paracetamol; Drug: IV saline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum Severity of Post-operative Pain

    5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting)

    Measured: The severest pain grade felt within a week

  2. Duration of Post-operative Pain

    4 selections (1 day, 2 days, 3 days, if more specify)

    Measured: number of days at which pain was experienced within the the 1st sevn days post -surgery

  3. Occurence of Post-operative Nausea

    Postoperative nausea occurence (yes, no)

    Measured: 7 days

  4. Onset of Post-operative Nausea

    Postoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day)

    Measured: onset of 1st ocurence of nausea attack within the 1st week post-surgery

  5. Duration of Post-operative Nausea

    Postoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify)

    Measured: 7 days

  6. Occurence of Postoperative Vomiting

    Postoperative vomiting occurrence (yes, no)

    Measured: 7 days

  7. Total Number of Post-operative Vomiting Episodes

    Postoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify)

    Measured: total number of post-operative vomiting episodes which were experienced within the 1st week post-surgery

Secondary outcomes (3)
  1. Onset of 1st Post-operative Oral Intake

    feeding onset (1st day i. surgery day, 2nd day, 3rd day)

    Measured: Onset of 1st post-operative oral intake recorded within the 1st 3days post-surgery

  2. Average Amount of Meal Per Day

    adequacy of meals (inadequate, adequate)

    Measured: 3 days

  3. Average Frequency of Meals Per Day

    average frequency of meals (1 meal, 2 meals, if more specify)

    Measured: average number of meals consumed per day for the 1st three days post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2015 (estimated)
  2. Study startJan 2013
  3. Primary completionMar 2014
  4. Study completionMar 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02401529
Sponsor's protocol ID
Bahammam-1
Status last verified
Jun 2015
First submitted
21 Mar 2015
Last updated
15 Jul 2015
Data monitoring committee
No

Publications

  • Elhakim M, Ali NM, Rashed I, Riad MK, Refat M. Dexamethasone reduces postoperative vomiting and pain after pediatric tonsillectomy. Can J Anaesth. 2003 Apr;50(4):392-7. doi: 10.1007/BF03021038. English, French.

    PubMed 12670818
  • Weimert TA, Babyak JW, Richter HJ. Electrodissection tonsillectomy. Arch Otolaryngol Head Neck Surg. 1990 Feb;116(2):186-8. doi: 10.1001/archotol.1990.01870020062016.

    PubMed 2297411
  • Leach J, Manning S, Schaefer S. Comparison of two methods of tonsillectomy. Laryngoscope. 1993 Jun;103(6):619-22. doi: 10.1288/00005537-199306000-00008.

    PubMed 8502095
  • Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist. 2007 Sep;12(9):1143-50. doi: 10.1634/theoncologist.12-9-1143.

    PubMed 17914084
  • Baxendale BR, Vater M, Lavery KM. Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia. 1993 Nov;48(11):961-4. doi: 10.1111/j.1365-2044.1993.tb07474.x.

    PubMed 8250191
  • Browning GG. Prophylactic steroids and/or antibiotics to reduce post-tonsillectomy morbidity: a yet unanswered conundrum. Clin Otolaryngol. 2010 Oct;35(5):417. doi: 10.1111/j.1749-4486.2010.02211.x. No abstract available.

    PubMed 21108754
  • Hermans V, De Pooter F, De Groote F, De Hert S, Van der Linden P. Effect of dexamethasone on nausea, vomiting, and pain in paediatric tonsillectomy. Br J Anaesth. 2012 Sep;109(3):427-31. doi: 10.1093/bja/aes249.

    PubMed 22879656
  • Park SK, Kim J, Kim JM, Yeon JY, Shim WS, Lee DW. Effects of oral prednisolone on recovery after tonsillectomy. Laryngoscope. 2015 Jan;125(1):111-7. doi: 10.1002/lary.24958. Epub 2014 Oct 7.

    PubMed 25291409
  • Andersen R, Krohg K. Pain as a major cause of postoperative nausea. Can Anaesth Soc J. 1976 Jul;23(4):366-9. doi: 10.1007/BF03005916.

    PubMed 7347
  • McKean S, Kochilas X, Kelleher R, Dockery M. Use of intravenous steroids at induction of anaesthesia for adult tonsillectomy to reduce post-operative nausea and vomiting and pain: a double-blind randomized controlled trial. Clin Otolaryngol. 2006 Feb;31(1):36-40. doi: 10.1111/j.1749-4486.2006.01141.x.

    PubMed 16441800
  • Beirne OR, Hollander B. The effect of methylprednisolone on pain, trismus, and swelling after removal of third molars. Oral Surg Oral Med Oral Pathol. 1986 Feb;61(2):134-8. doi: 10.1016/0030-4220(86)90173-8.

    PubMed 3457335
  • Campbell WI, Kendrick RW. Postoperative dental pain--a comparative study of anti-inflammatory and analgesic agents. Ulster Med J. 1991 Apr;60(1):39-43.

    PubMed 1853495
  • Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000 Jan;90(1):186-94. doi: 10.1097/00000539-200001000-00038.

    PubMed 10625002
  • Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE, Harris JP. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol. 2009 Jun;30(4):443-8. doi: 10.1097/MAO.0b013e3181a52773.

    PubMed 19395984
  • Thomas S, Beevi S. Epidural dexamethasone reduces postoperative pain and analgesic requirements. Can J Anaesth. 2006 Sep;53(9):899-905. doi: 10.1007/BF03022833.

    PubMed 16960268

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing IV dexamethasone, Oral prednisolone and Paracetamol in people with Postoperative Pain and Postoperative Nausea and Vomiting, run by King Fahd General Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Jul 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum Severity of Post-operative Pain (time frame: The severest pain grade felt within a week). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02401529, which also lists 25 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Effect of Steroids on Post-tonsillectomy Morbidities | AzTrials